- Home
- TTGT vs DNA Comparison
TTGT vs DNA Comparison
Compare TTGT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTGT
- DNA
- Stock Information
- Founded
- TTGT 1999
- DNA 2008
- Country
- TTGT United States
- DNA United States
- Employees
- TTGT N/A
- DNA N/A
- Industry
- TTGT Telecommunications Equipment
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTGT Telecommunications
- DNA Health Care
- Exchange
- TTGT Nasdaq
- DNA Nasdaq
- Market Cap
- TTGT 561.6M
- DNA 478.8M
- IPO Year
- TTGT 2007
- DNA N/A
- Fundamental
- Price
- TTGT $8.16
- DNA $7.85
- Analyst Decision
- TTGT Buy
- DNA Sell
- Analyst Count
- TTGT 7
- DNA 5
- Target Price
- TTGT $26.29
- DNA $17.25
- AVG Volume (30 Days)
- TTGT 387.6K
- DNA 1.6M
- Earning Date
- TTGT 05-08-2025
- DNA 05-08-2025
- Dividend Yield
- TTGT N/A
- DNA N/A
- EPS Growth
- TTGT N/A
- DNA N/A
- EPS
- TTGT N/A
- DNA N/A
- Revenue
- TTGT $260,750,999.00
- DNA $227,043,000.00
- Revenue This Year
- TTGT $44.39
- DNA N/A
- Revenue Next Year
- TTGT N/A
- DNA $16.85
- P/E Ratio
- TTGT N/A
- DNA N/A
- Revenue Growth
- TTGT 31.84
- DNA N/A
- 52 Week Low
- TTGT $7.66
- DNA $5.00
- 52 Week High
- TTGT $35.10
- DNA $45.20
- Technical
- Relative Strength Index (RSI)
- TTGT 28.61
- DNA 53.59
- Support Level
- TTGT $7.70
- DNA $7.93
- Resistance Level
- TTGT $8.91
- DNA $8.58
- Average True Range (ATR)
- TTGT 1.24
- DNA 0.81
- MACD
- TTGT -0.18
- DNA 0.36
- Stochastic Oscillator
- TTGT 6.98
- DNA 77.24
About TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.